Granted Patent
B2
US 7,982,043 · App. 12/136,357 · Granted Jul 19, 2011
Protein tyrosine kinase enzyme inhibitors
Assignee:
Wyeth LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
This invention provides compounds of formula 1, having the structure wherein R 1 , R 2 , R 3 , R 4 , and R 5 are described within the specification.
Claims (1)
1. A method of treating or inhibiting the growth of breast cancer in a mammal in need thereof, which method comprises administering to said mammal an effective amount of a compound, or a pharmaceutically acceptable salt thereof, selected from: (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide.
Assignments (2)
CHANGE OF ADDRESS FOR ASSIGNEE
Recorded Jul 26, 2017
From: WYETH LLC
To: WYETH LLC
Reel/Frame 043359/0523 →
Continuity (3)
Provisional Application
60560724
· Sep 15, 2003